|
JP5222131B2
(ja)
|
2006-03-30 |
2013-06-26 |
浩 前田 |
キャノロールまたはそのプロドラッグ（ｐｄ）を含む抗炎症剤および癌予防剤ならびにこれらを含む医薬、化粧品および食品
|
|
EP2058309A4
(en)
*
|
2006-08-04 |
2010-12-22 |
Takeda Pharmaceutical |
CONDENSED HETEROCYCLIC COMPOUND
|
|
JP5336375B2
(ja)
|
2006-08-30 |
2013-11-06 |
セルゾーム リミテッド |
キナーゼ阻害剤としてのトリアゾール誘導体
|
|
US8450336B2
(en)
|
2006-12-14 |
2013-05-28 |
Nps Pharmaceuticals, Inc |
Use of D-serine derivatives for the treatment of anxiety disorders
|
|
US8263585B2
(en)
|
2007-05-04 |
2012-09-11 |
Novartis Ag |
Organic compounds
|
|
US7928140B2
(en)
|
2007-08-02 |
2011-04-19 |
Amgen Inc. |
Benzothiazole PI3 kinase modulators for cancer treatment
|
|
CA2695251C
(en)
*
|
2007-08-14 |
2016-06-21 |
Bayer Schering Pharma Aktiengesellschaft |
Fused imidazoles for cancer treatment
|
|
EP2062893A1
(en)
*
|
2007-10-18 |
2009-05-27 |
Bayer Schering Pharma AG |
Fused imidazoles for cancer treatment
|
|
CA2696631A1
(en)
*
|
2007-08-17 |
2009-02-26 |
Icagen, Inc. |
Heterocycles as potassium channel modulators
|
|
US8431608B2
(en)
|
2007-08-17 |
2013-04-30 |
Icagen Inc. |
Heterocycles as potassium channel modulators
|
|
CA2691448A1
(en)
|
2007-08-31 |
2009-03-05 |
Dominique Swinnen |
Triazolopyridine compounds and their use as ask inhibitors
|
|
UA102828C2
(en)
|
2007-11-27 |
2013-08-27 |
Целльзом Лимитед |
Amino triazoles as p13k inhibitors
|
|
US7820665B2
(en)
|
2007-12-19 |
2010-10-26 |
Amgen Inc. |
Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
|
|
US8268834B2
(en)
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
US20090258907A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Abbott Laboratories |
Compounds useful as inhibitors of rock kinases
|
|
CN102083826A
(zh)
*
|
2008-04-16 |
2011-06-01 |
沃泰克斯药物股份有限公司 |
磷脂酰肌醇3-激酶的抑制剂
|
|
US20110105457A1
(en)
|
2008-04-18 |
2011-05-05 |
Shionogi & Co., Ltd. |
Heterocyclic compound having inhibitory activity on pi3k
|
|
WO2009133127A1
(en)
*
|
2008-04-30 |
2009-11-05 |
Merck Serono S.A. |
Fused bicyclic compounds and use thereof as pi3k inhibitors
|
|
WO2009155052A1
(en)
*
|
2008-05-28 |
2009-12-23 |
Wyeth |
3-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
|
|
JP5599783B2
(ja)
|
2008-05-30 |
2014-10-01 |
アムジエン・インコーポレーテツド |
Ｐｉ３キナーゼの阻害薬
|
|
AU2009259853A1
(en)
|
2008-06-20 |
2009-12-23 |
Genentech, Inc. |
Triazolopyridine JAK inhibitor compounds and methods
|
|
PE20110063A1
(es)
|
2008-06-20 |
2011-02-16 |
Genentech Inc |
DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
|
|
EP2311842A3
(en)
*
|
2008-06-24 |
2011-07-13 |
Takeda Pharmaceutical Company Limited |
PI3K/M TOR inhibitors
|
|
WO2010007100A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Ltd |
7-substituted amino triazoles as pi3k inhibitors
|
|
WO2010007099A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
|
WO2010057877A1
(en)
*
|
2008-11-18 |
2010-05-27 |
Cellzome Limited |
7-pyridinyl- or phenyl- substituted triazolo [1, 5 -a] pyridines as pi3k inhibitors
|
|
PL3354650T3
(pl)
|
2008-12-19 |
2022-06-13 |
Vertex Pharmaceuticals Incorporated |
Związki przydatne jako inhibitory kinazy atr
|
|
WO2010092015A1
(en)
|
2009-02-10 |
2010-08-19 |
Cellzome Limited |
Urea triazololo [1, 5-a] pyridine derivatives as pi3k inhibitors
|
|
EP2396324A1
(en)
|
2009-02-13 |
2011-12-21 |
Fovea Pharmaceuticals |
Ý1, 2, 4¨triazolo ý1, 5 -a¨pyridines as kinase inhibitors
|
|
CA2752596A1
(en)
|
2009-02-17 |
2010-08-26 |
Vertex Pharmaceuticals Incorporated |
Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
|
|
EP2401273A1
(en)
|
2009-02-27 |
2012-01-04 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
WO2010100144A1
(en)
*
|
2009-03-04 |
2010-09-10 |
Merck Serono S.A. |
Fused bicyclic compounds as inhibitors for pi3 kinase
|
|
CA2755285C
(en)
|
2009-03-20 |
2014-02-11 |
Yunxin Y. Bo |
Inhibitors of pi3 kinase
|
|
WO2010125799A1
(ja)
|
2009-04-27 |
2010-11-04 |
塩野義製薬株式会社 |
Pi3k阻害活性を有するウレア誘導体
|
|
WO2010133534A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Cellzome Limited |
Bicyclic amino substituted compounds as pi3k inhibitors
|
|
US8367830B2
(en)
|
2009-05-20 |
2013-02-05 |
Cellzome Ag |
Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
|
|
WO2010141796A2
(en)
|
2009-06-05 |
2010-12-09 |
Cephalon, Inc. |
PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
|
|
EP2448938B9
(en)
|
2009-06-29 |
2015-06-10 |
Incyte Corporation |
Pyrimidinones as pi3k inhibitors
|
|
US8293753B2
(en)
*
|
2009-07-02 |
2012-10-23 |
Novartis Ag |
Substituted 2-carboxamide cycloamino ureas
|
|
EA201200087A1
(ru)
|
2009-07-02 |
2012-07-30 |
Новартис Аг |
2-карбоксамиды циклоаминомочевин, которые являются ингибиторами pi3k
|
|
UA111579C2
(uk)
*
|
2009-08-17 |
2016-05-25 |
Інтеллікіне Ллк |
ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ
|
|
WO2011075643A1
(en)
|
2009-12-18 |
2011-06-23 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as pi3k inhibitors
|
|
EP2558463A1
(en)
|
2010-04-14 |
2013-02-20 |
Incyte Corporation |
Fused derivatives as i3 inhibitors
|
|
US8487102B2
(en)
*
|
2010-04-20 |
2013-07-16 |
Hoffmann-La Roche Inc. |
Pyrrazolopyridine compounds as dual NK1/NK3 receptor antagonists
|
|
WO2011137155A1
(en)
|
2010-04-28 |
2011-11-03 |
Bristol-Myers Squibb Company |
Imidazopyridazinyl compounds and their uses for cancer
|
|
WO2011143423A2
(en)
*
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
US9096584B2
(en)
*
|
2010-05-12 |
2015-08-04 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
JP2013526540A
(ja)
|
2010-05-12 |
2013-06-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｒキナーゼ阻害剤として有用な化合物
|
|
JP5836367B2
(ja)
|
2010-05-12 |
2015-12-24 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ａｔｒキナーゼ阻害剤として有用な化合物
|
|
JP5894980B2
(ja)
*
|
2010-05-24 |
2016-03-30 |
インテリカイン， エルエルシー |
複素環式化合物およびその使用
|
|
TW201204723A
(en)
|
2010-06-22 |
2012-02-01 |
Fovea Pharmaceuticals |
Heterocyclic compounds, their preparation and their therapeutic application
|
|
JP5961187B2
(ja)
|
2010-12-20 |
2016-08-02 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｐｉ３ｋ阻害剤としてのｎ−（１−（置換フェニル）エチル）−９ｈ−プリン−６−アミン
|
|
SG191291A1
(en)
*
|
2011-01-19 |
2013-07-31 |
Galapagos Nv |
Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
|
|
WO2012116237A2
(en)
|
2011-02-23 |
2012-08-30 |
Intellikine, Llc |
Heterocyclic compounds and uses thereof
|
|
TWI592411B
(zh)
|
2011-02-23 |
2017-07-21 |
英特爾立秦有限責任公司 |
激酶抑制劑之組合及其用途
|
|
US9108984B2
(en)
|
2011-03-14 |
2015-08-18 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
|
|
US9126948B2
(en)
|
2011-03-25 |
2015-09-08 |
Incyte Holdings Corporation |
Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
|
|
MX336865B
(es)
|
2011-04-07 |
2016-02-04 |
Bayer Pharma AG |
Imidazopiridazinas como inhibidores de quinasa akt.
|
|
MX389479B
(es)
|
2011-09-02 |
2025-03-20 |
Incyte Holdings Corp |
Heterociclilaminas como inhibidores de fosfoinositida 3-cinasas (pi3k)
|
|
AU2012315384B2
(en)
|
2011-09-30 |
2017-08-10 |
Vertex Pharmaceuticals Incorporated |
Treating pancreatic cancer and non-small cell lung cancer with ATR inhibitors
|
|
RU2018147217A
(ru)
|
2011-09-30 |
2019-01-18 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способы получения соединений, которые можно использовать в качестве ингибиторов киназы atr
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
CN104582795B
(zh)
|
2012-04-05 |
2018-04-20 |
沃泰克斯药物股份有限公司 |
可用作atr激酶抑制剂的化合物及其组合疗法
|
|
CN104350144B
(zh)
|
2012-05-23 |
2017-08-04 |
弗·哈夫曼-拉罗切有限公司 |
获得和使用内胚层和肝细胞的组合物和方法
|
|
ES2689429T3
(es)
*
|
2012-07-13 |
2018-11-14 |
Ucb Biopharma Sprl |
Derivados de imidazopiridina como moduladores de actividad de TNF
|
|
DK2904406T3
(en)
|
2012-10-04 |
2018-06-18 |
Vertex Pharma |
METHOD OF DETERMINING THE ATR INHIBITION, INCREASED DNA DAMAGE
|
|
HK1214533A1
(zh)
|
2013-03-15 |
2016-07-29 |
基因泰克公司 |
治疗癌症和预防癌症耐药性的方法
|
|
US9227978B2
(en)
|
2013-03-15 |
2016-01-05 |
Araxes Pharma Llc |
Covalent inhibitors of Kras G12C
|
|
AR095569A1
(es)
*
|
2013-03-20 |
2015-10-28 |
Hoffmann La Roche |
Derivados de urea
|
|
TWI659021B
(zh)
|
2013-10-10 |
2019-05-11 |
亞瑞克西斯製藥公司 |
Ｋｒａｓ ｇ１２ｃ之抑制劑
|
|
JP6496731B2
(ja)
|
2013-11-27 |
2019-04-03 |
シグナルケム・ライフサイエンシーズ・コーポレイションＳｉｇｎａｌｃｈｅｍ Ｌｉｆｅｓｃｉｅｎｃｅｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｔａｍファミリーキナーゼ阻害剤としてのアミノピリジン誘導体
|
|
GB201321733D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
EP3392244A1
(en)
|
2014-02-13 |
2018-10-24 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
WO2015123424A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
|
LT3105218T
(lt)
|
2014-02-13 |
2019-12-10 |
Incyte Corp |
Ciklopropilaminai kaip lsd1 inhibitoriai
|
|
US9598424B2
(en)
|
2014-03-06 |
2017-03-21 |
Takeda Pharmaceutical Company Limited |
Heteroarylamide inhibitors of TBK1
|
|
US10077277B2
(en)
|
2014-06-11 |
2018-09-18 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
US9758523B2
(en)
|
2014-07-10 |
2017-09-12 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as LSD1 inhibitors
|
|
WO2016007736A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyrazines as lsd1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
JO3556B1
(ar)
|
2014-09-18 |
2020-07-05 |
Araxes Pharma Llc |
علاجات مدمجة لمعالجة السرطان
|
|
JP6586463B2
(ja)
*
|
2014-12-19 |
2019-10-02 |
ヤンセン ファーマシューティカ エヌ．ベー． |
ＰＩ３Ｋβ阻害剤としての複素環連結イミダゾピリダジン誘導体
|
|
SG10201912302VA
(en)
|
2015-02-27 |
2020-02-27 |
Incyte Corp |
Salts of pi3k inhibitor and processes for their preparation
|
|
EA201792205A1
(ru)
|
2015-04-03 |
2018-02-28 |
Инсайт Корпорейшн |
Гетероциклические соединения как ингибиторы lsd1
|
|
AU2016245864C1
(en)
|
2015-04-10 |
2021-09-09 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
|
ES2856880T3
(es)
|
2015-04-15 |
2021-09-28 |
Araxes Pharma Llc |
Inhibidores tricíclicos condensados de KRAS y métodos de uso de los mismos
|
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
|
WO2016183060A1
(en)
|
2015-05-11 |
2016-11-17 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
|
US10144724B2
(en)
|
2015-07-22 |
2018-12-04 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
|
DK3334709T3
(da)
|
2015-08-12 |
2025-02-03 |
Incyte Holdings Corp |
Salte af en lsd1-hæmmer
|
|
US10975071B2
(en)
|
2015-09-28 |
2021-04-13 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
|
EP3356359B1
(en)
|
2015-09-28 |
2021-10-20 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
WO2017058902A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
EP3356347A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
US10730867B2
(en)
|
2015-09-28 |
2020-08-04 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
|
WO2017058728A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
WO2017058768A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
US11464774B2
(en)
|
2015-09-30 |
2022-10-11 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
KR102932353B1
(ko)
|
2015-11-16 |
2026-02-27 |
아락세스 파마 엘엘씨 |
치환된 헤테로사이클릭 그룹을 포함하는 2-치환된 퀴나졸린 화합물 및 이의 사용 방법
|
|
AU2017228398A1
(en)
|
2016-03-03 |
2018-10-18 |
Cornell University |
Small molecule IRE1-alpha inhibitors
|
|
CA3021678A1
(en)
|
2016-04-22 |
2017-10-26 |
Incyte Corporation |
Formulations of an lsd1 inhibitor
|
|
US11352328B2
(en)
|
2016-07-12 |
2022-06-07 |
Arisan Therapeutics Inc. |
Heterocyclic compounds for the treatment of arenavirus
|
|
US10646488B2
(en)
|
2016-07-13 |
2020-05-12 |
Araxes Pharma Llc |
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
|
|
JP2019529484A
(ja)
|
2016-09-29 |
2019-10-17 |
アラクセス ファーマ エルエルシー |
Ｋｒａｓ ｇ１２ｃ変異体タンパク質の阻害剤
|
|
US10377743B2
(en)
|
2016-10-07 |
2019-08-13 |
Araxes Pharma Llc |
Inhibitors of RAS and methods of use thereof
|
|
EP3573954A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
|
US11136308B2
(en)
|
2017-01-26 |
2021-10-05 |
Araxes Pharma Llc |
Substituted quinazoline and quinazolinone compounds and methods of use thereof
|
|
EP3573971A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
|
JP7327802B2
(ja)
|
2017-01-26 |
2023-08-16 |
アラクセス ファーマ エルエルシー |
縮合ヘテロ－ヘテロ二環式化合物およびその使用方法
|
|
WO2018140599A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
Benzothiophene and benzothiazole compounds and methods of use thereof
|
|
CN110869358A
(zh)
|
2017-05-25 |
2020-03-06 |
亚瑞克西斯制药公司 |
Kras的共价抑制剂
|
|
WO2018218069A1
(en)
|
2017-05-25 |
2018-11-29 |
Araxes Pharma Llc |
Quinazoline derivatives as modulators of mutant kras, hras or nras
|
|
TW201906832A
(zh)
|
2017-05-25 |
2019-02-16 |
美商亞瑞克西斯製藥公司 |
用於癌症治療之化合物及其使用方法
|
|
MX2020003593A
(es)
|
2017-10-02 |
2020-07-22 |
1St Biotherapeutics Inc |
Compuestos de benzotiazol y metodos para usar los mismos para tratar trastornos neurodegenerativos.
|
|
CN111566103B
(zh)
*
|
2017-10-30 |
2023-06-23 |
百时美施贵宝公司 |
作为激酶抑制剂的氨基咪唑并吡嗪
|
|
BR112020012651A2
(pt)
*
|
2017-12-22 |
2020-12-01 |
Ravenna Pharmaceuticals, Inc. |
compostos derivados de aril-bipiridina amina como inibidores da fosfatidilinositol fosfato quinase, composição farmacêutica compreendendo os mesmos e usos terapêuticos dos ditos compostos
|
|
WO2019126731A1
(en)
*
|
2017-12-22 |
2019-06-27 |
Petra Pharma Corporation |
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
|
KR20200118005A
(ko)
*
|
2018-02-05 |
2020-10-14 |
위니베르시떼 드 스트라스부르 |
통증 치료용 화합물 및 조성물
|
|
EP3801069A4
(en)
|
2018-06-01 |
2022-03-16 |
Cornell University |
COMBINATION THERAPY FOR A PI3K-ASSOCIATED DISEASE OR DISORDER
|
|
IL278889B2
(en)
|
2018-06-01 |
2025-11-01 |
Incyte Corp |
Dosing regimen for the treatment of pi3k related disorders
|
|
BR112021001709A2
(pt)
|
2018-08-01 |
2021-05-04 |
Araxes Pharma Llc |
compostos espiro heterocíclicos e métodos de uso dos mesmos para o tratamento de câncer
|
|
US10968200B2
(en)
|
2018-08-31 |
2021-04-06 |
Incyte Corporation |
Salts of an LSD1 inhibitor and processes for preparing the same
|
|
US12419865B2
(en)
|
2018-12-06 |
2025-09-23 |
Arisan Therapeutics Inc. |
Compounds for the treatment of arenavirus infection
|
|
JP2022521537A
(ja)
*
|
2019-02-22 |
2022-04-08 |
ファースト・バイオセラピューティクス・インコーポレイテッド |
イミダゾピリジニル化合物及び増殖性障害の処置のためのその使用
|
|
KR20210126146A
(ko)
*
|
2019-03-07 |
2021-10-19 |
주식회사 퍼스트바이오테라퓨틱스 |
Pet 방사선추적자로서의 [18f]-라벨링된 벤조티아졸 유도체
|
|
US10385046B1
(en)
|
2019-03-19 |
2019-08-20 |
1ST Biotherapeutics, Inc. |
Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders
|
|
WO2020194260A1
(en)
*
|
2019-03-28 |
2020-10-01 |
1ST Biotherapeutics, Inc. |
Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof
|
|
WO2020201773A1
(en)
*
|
2019-04-05 |
2020-10-08 |
Storm Therapeutics Ltd |
Mettl3 inhibitory compounds
|
|
TW202112767A
(zh)
|
2019-06-17 |
2021-04-01 |
美商佩特拉製藥公司 |
作為磷脂酸肌醇磷酸激酶抑制劑之胺基吡啶衍生物
|
|
WO2021138391A1
(en)
|
2019-12-30 |
2021-07-08 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
CN112047950B
(zh)
*
|
2020-09-14 |
2023-07-25 |
华东师范大学 |
咪唑并吡嗪类衍生物及其合成方法和应用
|
|
US11744824B2
(en)
*
|
2020-09-15 |
2023-09-05 |
1ST Biotherapeutics, Inc. |
2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds
|
|
WO2022064458A1
(en)
*
|
2020-09-28 |
2022-03-31 |
1ST Biotherapeutics, Inc. |
Indazoles as hematopoietic progenitor kinase 1 (hpk1) inhibitors and methods of using same
|
|
WO2022071434A1
(ja)
|
2020-09-30 |
2022-04-07 |
住友化学株式会社 |
複素環化合物及びそれを含有する有害節足動物防除組成物
|
|
CN116425757B
(zh)
*
|
2022-01-13 |
2025-05-20 |
浙江同源康医药股份有限公司 |
多环类化合物及其用途
|
|
CN115850263B
(zh)
*
|
2022-12-28 |
2025-06-17 |
浙江工业大学 |
一种2,7-二取代苯并噻唑类化合物及其应用
|
|
CN119841829B
(zh)
*
|
2023-10-18 |
2026-06-30 |
中国科学院合肥物质科学研究院 |
用于治疗PI3Kγ介导的疾病的化合物及其用途
|